1. Inicio
  2. Publicaciones
  3. Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU; Abordaje del tratamiento antitrombótico durante el perioperatorio y el periprocedimiento: documento de consenso 2025 de SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT y AEU

Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU; Abordaje del tratamiento antitrombótico durante el perioperatorio y el periprocedimiento: documento de consenso 2025 de SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT y AEU

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Vivas Balcones, D.
  • Anguita Sánchez, M.
  • Anguita-Gámez, M.
  • Arcelus, J.I.
  • Echeverri, M.
  • Egocheaga, I.
  • Esteve-Pastor, M.A.
  • Ferreiro, J.L.
  • Llau-Pitarch, J.V.
  • Roldan-Schilling, V.
  • Ruíz-Nodar, J.M.R.
  • Gonzalez-Casal, D.
  • Torres-Fonseca, M.
  • Lopez-Menendez, J.
  • Ciria, M.
  • Leyva, F.
  • Rodríguez de Santiago, E.R.
  • Vidán, M.T.
  • Pamplona, L.
  • Mingot Castellano, M.E.
  • Mateo-Arranz, J.
  • Polo, J.
  • Castellanos, Á.
  • Llanos Jorge, C.
  • Madridano, O.
  • Jiménez, S.
  • Freijo, M.D.M.
  • Puchades, M.J.
  • Lafuente, J.
  • Jimenez, D.
  • Santos-Bueso, E.
  • Ferrándis, E.
  • Figuero, E.
  • González-Nieto, C.J.
  • Castel, A.
  • Hermida, J.F.
  • Marín, F.
  • Rodríguez-padial, L.
  • Fernández-Lozano, I.
  • Hidalgo, F.
  • Cassinello, C.
  • Muñoz, E.
  • Palomo-Lopez, N.

Grupos

Abstract

In recent years, the use of anticoagulant and antiplatelet medications has significantly increased, along with rising life expectancy. As a result, many patients on antithrombotic therapy will eventually require invasive procedures. This necessitates decisions on the appropriateness and timing of discontinuing anticoagulation and/or antiplatelet therapy in each case. Although a key multidisciplinary consensus document was published in 2018 to guide this process, its practical application has been limited. Furthermore, adherence to its recommendations has been low, leading to a higher incidence of both thrombotic and hemorrhagic adverse events. To address these issues and reflect advances in knowledge, it has been decided to update the previous consensus document to include developments since 2018. The aim is to simplify clinical decision-making and gain support from a broader range of scientific societies. Ultimately, the goal is to improve the dissemination and practical application of these recommendations to optimize the safety and effectiveness of antithrombotic treatment in patients requiring invasive procedures, reduce complications associated with inappropriate treatment, and enhance clinical outcomes in this increasingly complex scenario. Full English text available from:www.revespcardiol.org/en © 2025 Sociedad Española de Cardiología

Datos de la publicación

ISSN/ISSNe:
0300-8932, 1579-2242

REVISTA ESPANOLA DE CARDIOLOGIA  EDICIONES DOYMA S A

Tipo:
Article
Páginas:
68-79
PubMed:
40983168
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
0,407 SCImago ℠
Cuartil:
Q3 SCImago ℠

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • anticoagulant agent; antithrombocytic agent; fibrinolytic agent; adverse drug reaction; anticoagulant therapy; Article; bleeding; clinical decision making; clinical outcome; consensus; drug efficacy; drug safety; human; incidence; invasive procedure; medication compliance; patient compliance; perioperative care; thrombosis; practice guideline; prevention and control; procedures; Anticoagulants; Consensus; Fibrinolytic Agents; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Thrombosis

Campos de Estudio

Cita

Compartir